RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 97 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2016. The put-call ratio across all filers is 4.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,893,000 | +182.8% | 1,214,418 | +69.2% | 0.01% | +166.7% |
| Q2 2016 | $3,852,000 | +21.1% | 717,543 | +3.7% | 0.00% | +50.0% |
| Q1 2016 | $3,181,000 | -41.4% | 691,661 | -33.8% | 0.00% | -50.0% |
| Q4 2015 | $5,427,000 | +98.1% | 1,044,208 | +130.3% | 0.00% | +100.0% |
| Q3 2015 | $2,740,000 | -59.7% | 453,345 | +5.2% | 0.00% | -50.0% |
| Q2 2015 | $6,803,000 | +22.6% | 431,005 | -15.6% | 0.00% | +33.3% |
| Q1 2015 | $5,551,000 | +321.5% | 510,875 | +307.3% | 0.00% | +200.0% |
| Q4 2014 | $1,317,000 | -3.7% | 125,443 | -12.2% | 0.00% | 0.0% |
| Q3 2014 | $1,368,000 | -2.6% | 142,893 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,405,000 | +153.2% | 121,718 | +119.0% | 0.00% | – |
| Q1 2014 | $555,000 | +15.1% | 55,571 | +49.5% | 0.00% | – |
| Q4 2013 | $482,000 | -63.9% | 37,161 | -58.6% | 0.00% | -100.0% |
| Q3 2013 | $1,336,000 | – | 89,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |